TOP

LOGIN
Products
Products
Products
You are viewing the International version of this page; click here for other versions.
Products Services Knowledge

At Gen Re, we believe that information and collaboration are the basis for great innovation.

We leverage the actuarial, medical, and underwriting expertise of our global units with the market-specific knowledge of our regional departments to support your product initiatives.

Our product development support comprises a wide range of services needed by primary insurers, including design of new products, calculation of the respective rates, and development of policy terms and conditions. Post-launch, our portfolio monitoring and experience studies offer additional valuable insights.

Our Products

Card Image

Mortality

Card Image

Longevity

Card Image

Disability

Card Image

Critical Illness/
Dread Disease

Card Image

Health

Card Image

Long Term Care

Our Services

Underwriting

Risk assessment of individual lives is a core strength at Gen Re. We offer services in all areas of risk assessment.

Learn More

Market Research & Surveys

Understand biometric risks – from single portfolios to market-wide surveys.

Learn More

Analytics

Using a wide range of techniques such as random forest, GLMs or neural networks our data scientists get the most of complex data; always in collaborations with our experts from other fields a maximum of insights and interpretability is achieved.

Learn More

Digital Solutions

We help our clients create digital solutions across the insurance value chain.

Learn More

Recent Research

Publication
Diabetes and Critical Illness Insurance – Bridging the Protection Gap
Diabetes affects millions and is often undiagnosed. It increases risk for critical illnesses. CI insurance is evolving to support prevention, wellness, and broader coverage – even for prediabetics and diabetics – helping close the protection gap.
Samuel Lim, Winncy Wong 14 November 2025
Read More
Publication
The Potential Yo-Yo Mortality Effects of GLP-1s After Discontinuation [Webinar]
Little is known about the durability of GLP-1’s impact on improved mortality risk. There appears to be a behavioral risk gap between adherence and consistent GLP-1 usage. A credible actuarial framework for post-GLP-1 trajectories is needed especially for segmentation of completers vs. drop-offs.
Dr. Susan Stegman, Heather Majewski 17 September 2026
Read More
Publication
Gen Re Validates Milliman Irix® Risk Score 4.0 – Unlocking Additional Insights Quantifying the Value of Data [Use Case #2 Whitepaper Available]
Gen Re produced an independent assessment of Milliman’s latest generation of risk scoring for mortality underwriting using Prescription, Medical and Claims Data – demonstrating its predictive power and practical underwriting value. Read our second blog with a Use Case #2 for moving to this new tool.
Donna Sivigny 8 September 2026
Read More
Publication
Disability Risk in Cancer Survivors – An Insurance Perspective
As cancer survival and quality of life improve, Disability insurance for working-age survivors is increasingly relevant. This article highlights disability risks across the cancer journey, including late effects of disease and treatment that may affect productivity and work capacity.
Dr. Åsa Weber 3 September 2026
Read More
Publication
Malaysia Critical Illness Data Insights 2019–2024: Key Takeaways for the Market [Infographic]
The Malaysia CI insurance market has grown steadily, with more people buying coverage early in life. Claims are showing an increase in early-stage illnesses and older claimants. Cancer remains a leading cause for women, while heart disease is prominent for men, highlighting evolving health risks.
Samuel Lim, Wendy Low 20 August 2026
Read More

Find an Expert in Your Region